Intelligence Feed event · Commodity · 2026-10-13

    Albemarle Falls 2.73% to $98.51 as Monthly Drop Widens to 13.83%

    Question

    Albemarle Falls 2.73% to $98.51 as Monthly Drop Widens to 13.83%

    Direct answer

    Shares of Albemarle declined 2.73% to close at $98.51 on October 12, 2026, lagging the broader market and expanding the stock's one-month decline to 13.83%. Despite consensus projections indicating Q3 EPS of $2.44 due to weak comparisons in the prior-year period, persistent negative analyst revisions have kept the name at a Zacks Rank #5 (Strong Sell), reflecting ongoing headwinds across lithium chemical markets.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-13
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Albemarle Falls 2.73% to $98.51 as Monthly Drop Widens to 13.83%”, revision 1, evidence through 2026-10-13. https://marketontology.com/market-events/2026-10-13/albemarle-falls-2-73-to-98-51-as-monthly-drop-widens-to-13-83-df2aca

    COMMODITY
    Albemarle Falls 2.73% to $98.51 as Monthly Drop Widens to 13.83%
    Shares of Albemarle declined 2.73% to close at $98.51 on October 12, 2026, lagging the broader market and expanding the stock's one-month decline to 13.83%. Despite consensus projections indicating Q3 EPS of $2.44 due to weak comparisons in the prior-year period, persistent negative analyst revisions have kept the name at a Zacks Rank #5 (Strong Sell), reflecting ongoing headwinds across lithium chemical markets.
    ALB
    Impact
    69
    OCT 13
    SIG
    88%
    ALB
    Albemarle Falls 2.73% to $98.51 as Monthly Drop Widens to 13.83%
    Shares of Albemarle declined 2.73% to close at $98.51 on October 12, 2026, lagging the broader market and expanding the stock's one-month decline to 13.83%. Despite consensus projections indicating Q3 EPS of $2.44 due to weak comparisons in the prior-year period, persistent negative analyst revisions have kept the name at a Zacks Rank #5 (Strong Sell), reflecting ongoing headwinds across lithium chemical markets.
    → Falling spot lithium pricing pressures producer equity multiples despite base-effect comparisons in quarterly earnings forecasts.
    Impact
    Shares of Albemarle declined 2.73% to close at $98.51 on October 12, 2026, lagging the broader market and expanding the stock's one-month decline to 13.83%. Despite consensus projections indicating Q3 EPS of $2.44 due to weak comparisons in the prior-year period, persistent negative analyst revisions have kept the name at a Zacks Rank #5 (Strong Sell), reflecting ongoing headwinds across lithium chemical markets.
    Affected
    ALB
    Transmission
    Falling spot lithium pricing pressures producer equity multiples despite base-effect comparisons in quarterly earnings forecasts.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    ALBlithium chemical price realization and multiple contractionDown1-4wSource reported ALB fell 2.73% to $98.51 with a 13.83% monthly drop and Zacks Rank #5.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month